VSee Health, Inc. - Common Stock (VSEE)

As investors continue searching for high-upside opportunities across the nanocap market, several companies are generating attention through corporate actions, strategic acquisitions, commercial expansion, and exposure to high-growth sectors including artificial intelligence, critical minerals, telehealth, advanced manufacturing, and robotics . While nanocap stocks carry elevated risk and volatility, these companies are executing initiatives that have placed them on many speculative investors' watchlists.

The acquisition is expected to close fairly quickly and without any initial shareholder dilution

Proposed acquisition, valued at $42 million, could add over $35 million in annualized revenue and more than $7 million in earnings

HOUSTON, TX / ACCESS Newswire / July 28, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today announced that its Board of Directors has initiated a comprehensive strategic review aimed at pursuing transformational opportunities to accelerate growth and maximize shareholder value.

HOUSTON, TX / ACCESS Newswire / July 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today reaffirmed its commitment to protecting shareholder value by minimizing dilution while maintaining the financial flexibility needed to execute its growth strategy. Our Board of Directors has approved a proposed maximum of an 80-for-1 reverse stock split, subject to the completion of all applicable regulatory requirements and shareholder approvals. This action is intended to better align our capital structure with our long-term strategic objectives and support our continued Nasdaq listing. The company wants to affirm with its shareholders, the upcoming reverse split has been corrected from max of up to 250 to no more than 80 to 1.

VSee Health (Nasdaq: VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. VSEE offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers.

VSEE's Telehealth Platform is Positioned at the Center of Healthcare's AI Transformation

HOUSTON, TX / ACCESS Newswire / July 9, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today issued the following letter from Chairman and Chief Executive Officer Dr. Imoigele Aisiku providing shareholders with an update on the Company's strategic transformation and outlook.

Key Driver for its Enterprise Telehealth Revenue Acceleration

VSee Health (Nasdaq: VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. VSEE offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers.

Refocus on Telehealth and Digital Health Solutions That Provided 80% Revenue Growth in 2025

HOUSTON, TX / ACCESS Newswire / June 11, 2026 / VSee Health, Inc. (NASDAQ:VSEE) today announced the completion of a transformative strategic transaction that separates the Company from its former laboratory subsidiary, VSee Lab, eliminates a significant block of outstanding shares, and positions VSee Health to focus exclusively on its core telehealth and digital health platform businesses.

VSee Health (Nasdaq: VSEE ) is a leading provider of telehealth solutions, specializing in real-time virtual care, clinical review, and billing services. Its technology powers healthcare networks and organizations worldwide, enabling seamless patient-provider interactions and ensuring efficient care delivery. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, VSEE highly scalable, customizable telehealth building blocks each meet stringent security standards.

SAN JOSE, CA / ACCESS Newswire / April 1, 2026 / VSee Health, Inc. (Nasdaq:VSEE), a leader in AI-powered telehealth technology and high-acuity virtual care solutions, today reported its financial and operational results for the full year ended December 31, 2025. The Company delivered strong top-line growth and meaningful margin improvement while significantly narrowing its net loss.

VSee Health (Nasdaq: VSEE ) is a leading provider of telehealth solutions, specializing in real-time virtual care, clinical review, and billing services. Its technology powers healthcare networks and organizations worldwide, enabling seamless patient-provider interactions and ensuring efficient care delivery. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, VSEE highly scalable, customizable telehealth building blocks each meet stringent security standards.

Autonomous, AI-Powered Robot Navigates Directly to Patients' Bedsides - No Staff Escort Required

VSee Health (Nasdaq: VSEE ) is a leading provider of telehealth solutions, specializing in real-time virtual care, clinical review, and billing services. Its technology powers healthcare networks and organizations worldwide, enabling seamless patient-provider interactions and ensuring efficient care delivery. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, VSEE highly scalable, customizable telehealth building blocks each meet stringent security standards.

SAN JOSE, CA / ACCESS Newswire / February 5, 2026 / VSEE Health, Inc. (NASDAQ:VSEE), a provider of AI-enabled telehealth and enterprise virtual care solutions, today announced a strategic managed services partnership with GoMyRx, a digital prescription fulfillment platform and affiliate company of the GoMyDocs healthcare ecosystem, designed to expand integrated digital healthcare delivery capabilities and support telehealth-enabled medication fulfillment nationwide.

VSee's Rapidly Configurable AI Telehealth Platform Addresses Rural Hospital Access and Financial Sustainability